Tenet Healthcare Corporation

NYSE:THC

162.41 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986
Revenue 20,54819,17419,48517,64018,47918,31319,17919,62118,63416,61511,1029,1198,8549,2059,0148,6638,8528,7019,6149,91913,212012,05311,41410,8809,8958,6915,5593,3182,9673,761.83,9823,8063,9353,6763,2022,8813,595
Cost of Revenue 18,1213,2733,3282,9823,0573,0043,0853,1242,9632,6301,7841,5525,6645,4775,4265,3445,5375,4706,1626,0498,15704,2804,1203,8673,4467,8344,4602,6952,4553,1633,2763,0653,2523,0932,6802,3762,515
Gross Profit 2,42715,90116,15714,65815,42215,30916,09416,49715,67113,9859,3187,5673,1903,7283,5883,3193,3153,2313,4523,8705,05507,7737,2947,0136,4498571,099623512598.87067416835835225051,080
Gross Profit Ratio 0.1180.8290.8290.8310.8350.8360.8390.8410.8410.8420.8390.830.360.4050.3980.3830.3740.3710.3590.390.38300.6450.6390.6450.6520.0990.1980.1880.1730.1590.1770.1950.1740.1590.1630.1750.3
Reseach & Development Expenses 00000000000000000000000000000000000000
General & Administrative Expenses 9,1468,8448,8788,4188,7048,6349,2749,3569,0118,0235,3714,25700002,6142,5442,8813,436005,5295,3595,1554,640000000000000
Selling & Marketing Expenses 00000000000000000000000000000000000000
SG&A 9,1468,8448,8788,4188,7048,6349,2749,3569,0118,0235,3714,25700002,6142,5442,8813,43612,15105,5295,3595,1554,64000000000000633
Other Expenses 194,6454,8704,1005,039-5-225,7095,2804,8593,1502,5372,4583,0721,0831,0054321,4709191,7112,6230697533556460443321195198199196172170157139129130
Operating Expenses 14,51513,48913,74812,51813,74313,69214,70515,06514,29112,8828,5216,7942,4583,0721,0833,0013,0464,0143,8005,14714,77406,2265,8925,7115,100443321195198199196172170157139129763
Operating Income 2,4272,3332,8711,9891,5131,6471,1131,2191,0569256637497326562,5052,3142922821375257201,6251,6861,6381,565405476380198462.8698539483399357353294
Operating Income Ratio 0.1180.1220.1470.1130.0820.090.0580.0620.0570.0560.060.0820.0830.0710.2780.2670.0330.0320.0140.0050.04300.1350.1480.1510.1580.0470.0860.1150.0670.1230.1750.1420.1230.1090.1110.1230.082
Total Other Income Expenses Net -810-989-983-1,318-1,21726-462-205-324-202-481-27-196-74-1,855115-23-1,065-485-1,329-2,1340-78-284-336-216930248116-63-188303027262323
Income Before Tax 1,6171,3441,888671296639-101248144147-15833416115820537-107-1,133-708-1,613-1,84101,142618474647-21746329359.9259230472405316284279209
Income Before Tax Ratio 0.0790.070.0970.0380.0160.035-0.0050.0130.0080.009-0.0140.0370.0180.0170.0230.004-0.012-0.13-0.074-0.163-0.13900.0950.0540.0440.065-0.0020.1340.0990.1210.0690.0580.1240.1030.0860.0890.0970.058
Income Tax Expense 306344411-97153176219676849-6512561-977-23-25-58-262-87184-437046427822526952348135144999719516312411413991
Net Income 6111,0001,477768143111-704-192-14012-134152821,14318725-89-803-708-2,640-1,4770785302249261-254349.8183-425.11601042772421431486394
Net Income Ratio 0.030.0520.0760.0440.0080.006-0.037-0.01-0.0080.001-0.0120.0170.0090.1240.0210.003-0.01-0.092-0.074-0.266-0.11200.0650.0260.0230.026-0.0290.0630.055-0.1430.0430.0260.0730.0610.0390.0460.0220.026
EPS 6.019.3513.837.311.381.09-7-1.93-1.410.12-1.321.350.499.241.520.2-0.75-6.82-6.04-22.65-12.6705.362.582.142.27-2.234.522.76-6.792.561.64.624.062.562.671.091.57
EPS Diluted 5.839.0513.67.231.381.07-7-1.93-1.410.12-1.321.30.488.161.480.2-0.75-6.82-6.04-22.65-12.6705.252.562.122.23-2.234.372.43-6.792.431.64.113.582.42.451.091.57
EBITDA 3,2973,4793,4963,1672,6992,5642,3812,4132,2761,9521,3421,2031,1451,0812,8917076546245194401,04302,1792,2192,1942,025848797575396661.8894711653556496482424
EBITDA Ratio 0.160.1810.1790.180.1460.140.1240.1230.1220.1170.1210.1320.1290.1170.3210.0820.0740.0720.0540.0440.07900.1810.1940.2020.2050.0980.1430.1730.1330.1760.2250.1870.1660.1510.1550.1670.118